State University of New York - Upstate Medical University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, State University of New York - Upstate Medical University sits in the top decile of US sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count).
State University of New York - Upstate Medical University: 113 sponsored US clinical trials, 8 recruiting.
State University of New York - Upstate Medical University sponsors 113 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 75 completed. 15 of these trials are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 2 trials.
Top-decile sponsor footprint
State University of New York - Upstate Medical University ranks in the top decile of sponsors by registered trial count (#226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
75 of 103 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (72.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
113 total, page 2 of 3
False/Negative Rate of Lung Percutaneous Needle Biopsy
NCT00638352
Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic Fibrosis
NCT01343524
Diabetes Support Project: Couples Intervention
NCT01017523
Computerized Cognitive Skills Training for Adolescents With Velocardiofacial Syndrome
NCT00917189
Dexamethasone Versus Depo Medrol in Lumbar Epidurals
NCT01397552
Magnetic Resonance Imaging (MRI) Interpretations for Lumbar Spinal Stenosis (LSS)
NCT01017692
Investigation of Neuroserpin as an Autism Candidate Gene
NCT00917683
Cyclobenzaprine Extended Release (ER) for Fibromyalgia
NCT01041495
Lumbar Disc Herniation Outcome Measures
NCT01041391
Analysis of Tokuhashi Score
NCT01210508
Prospective Study of Rapamycin for the Treatment of SLE
NCT00779194
Diabetes Prevention and Control in the Workplace: A Pilot Study
NCT00739336
Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia
NCT00727103
Pilot Study of Dietary Modification of Appetite Set Point in Obesity
NCT00726271
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
NCT00660218
Genetic Modifiers for 22q11.2 Syndrome
NCT00916955
Neuromuscular Characteristics of Individuals With Down Syndrome (DS)
NCT00643955
Assessment of the Stroke Rehabilitation Assessment of Movement as a Clinical Tool
NCT00635661
Organization in Acute Atrial Fibrillation Post Open Heart Surgery
NCT00614107
Does Chewing Gum After Elective Laparoscopic Colectomy Surgery Decrease Ileus?
NCT00632801
Effect of Using a Structured Tobacco Cessation Education Program
NCT00683228
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
NCT00617955
Body Water Content Sensor
NCT00643721
An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue
NCT00678691
Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture
NCT00643175
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
NCT00453609
Perceptions of Touch in People With Cancer
NCT00631735
School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus
NCT00566475
A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
NCT00411398
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
NCT00461890
An fMRI Study of Attention and Effort After Concussion
NCT00653029
Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
NCT00620984
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
NCT00652678
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804
An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants
NCT00591565
In Vivo Arthroscopic Behavior of the Infrapatellar Plica of the Knee
NCT00643487
Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers
NCT00615485
Improving Diabetes Outcomes: a Couples Intervention
NCT00250731
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
NCT00639171
Genetic Disease Gene Identification
NCT00916903
Advancing Research and Clinical Practice Through Close Collaboration (ARCC): A Pilot Test of an Intervention to Improve Evidence-Based Care and Patient Outcomes
NCT00635869
Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
NCT00639405
Parents Reading Comprehension of Their Child's Post-Operative Medicine Fact Sheets
NCT00639470
Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions
NCT00147823
Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction
NCT00174850
Aripiprazole as Augmentation for TRD
NCT00174876
Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder
NCT00145678
Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
NCT00641238
Use of Radiostereometric Analysis (RSA) Following Spinal Fusion Versus the DYNESYS Stabilization System
NCT00152165
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the State University of New York - Upstate Medical University pipeline
8 recruiting of 113 indexed (7% open); 75 completed (66%).
Phase mix: 15 late (III/IV) vs 21 early (I/II) (balanced across stages).
Top condition: Stroke (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
State University of New York - Upstate Medical University: open-pipeline peers nationwide
Peers matched on 113 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
State University of New York - Upstate Medical University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 113 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Bristol-Myers Squibb · 7% recruiting · 1,025 trials
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Kaiser Permanente · 7% recruiting · 294 trials
Related
What to do with this State University of New York - Upstate Medical University page
113 registered trials is a research-attention snapshot, not an endorsement of State University of New York - Upstate Medical University or any single study.
- 8 of State University of New York - Upstate Medical University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition State University of New York - Upstate Medical University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
State University of New York - Upstate Medical University pipeline card: 113 registered trials from official public datasets.Report a data error.